Загрузка...
Application and Progress of Combined Mesenchymal Stem Cell Transplantation in the Treatment of Ischemic Cardiomyopathy
Treatment of ischemic cardiomyopathy caused by myocardial infarction (MI) using mesenchymal stem cell (MSC) transplantation is a widely researched field, with promising clinical application. However, the low survival rate of transplanted cells has a severe impact on treatment outcome. Currently, res...
Сохранить в:
| Опубликовано в: : | Biomed Res Int |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4532814/ https://ncbi.nlm.nih.gov/pubmed/26295041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/568502 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|